$65.52
0.16[0.24%]
Last update: 3:38PM Get Real Time Here
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
04/17/2024 | ANIP | ANI Pharmaceuticals | FY | 2024 | $4.26 | $4.67 | $4.47 | $520.00M | $542.00M | $534.15M | Get Alert |
03/12/2024 | ANIP | ANI Pharmaceuticals | FY | 2024 | $4.26 | $4.67 | $4.46 | $520.00M | $542.00M | $535.28M | Get Alert |
02/29/2024 | ANIP | ANI Pharmaceuticals | FY | 2024 | $4.26 | $4.67 | $4.33 | $520.00M | $542.00M | $501.09M | Get Alert |
11/08/2023 | ANIP | ANI Pharmaceuticals | FY | 2023 | $4.29 | $4.57 | $4.08 | $468.00M | $478.00M | $452.94M | Get Alert |
09/12/2023 | ANIP | ANI Pharmaceuticals | FY | 2023 | $3.62 | $4.11 | $3.97 | $425.00M | $445.00M | $442.97M | Get Alert |
08/30/2023 | ANIP | ANI Pharmaceuticals | FY | 2023 | $3.62 | $4.11 | $3.97 | $425.00M | $445.00M | $442.97M | Get Alert |
08/09/2023 | ANIP | ANI Pharmaceuticals | FY | 2023 | $3.62 | $4.11 | $3.31 | $425.00M | $445.00M | $406.41M | Get Alert |
06/09/2023 | ANIP | ANI Pharmaceuticals | FY | 2023 | — | — | — | $385.00M | $410.00M | $403.52M | Get Alert |
05/08/2023 | ANIP | ANI Pharmaceuticals | FY | 2023 | $2.99 | $3.45 | $2.43 | $385.00M | $410.00M | $361.82M | Get Alert |
03/09/2023 | ANIP | ANI Pharmaceuticals | FY | 2023 | $2.09 | $2.59 | $2.62 | $360.00M | $385.00M | $352.49M | Get Alert |
11/09/2022 | ANIP | ANI Pharmaceuticals | FY | 2022 | $1.34 | $1.62 | $1.37 | $295.00M | $315.00M | $302.88M | Get Alert |
08/08/2022 | ANIP | ANI Pharmaceuticals | FY | 2022 | $1.34 | $1.62 | $1.43 | $295.00M | $315.00M | $304.50M | Get Alert |
05/10/2022 | ANIP | ANI Pharmaceuticals | FY | 2022 | $1.34 | $1.62 | $1.15 | $295.00M | $315.00M | $292.77M | Get Alert |
03/15/2022 | ANIP | ANI Pharmaceuticals | FY | 2022 | — | — | — | $260.00M | $275.00M | $301.57M | Get Alert |
02/27/2020 | ANIP | ANI Pharmaceuticals | FY | 2020 | $4.46 | $4.86 | $5.47 | $213.00M | $223.00M | $229.15M | Get Alert |
12/03/2019 | ANIP | ANI Pharmaceuticals | FY | 2019 | $5.06 | $5.23 | $5.14 | $209.00M | $212.00M | $209.67M | Get Alert |
11/06/2019 | ANIP | ANI Pharmaceuticals | FY | 2019 | $5.06 | $5.23 | $5.73 | $209.00M | $212.00M | $222.67M | Get Alert |
08/07/2019 | ANIP | ANI Pharmaceuticals | FY | 2019 | $5.57 | $6.21 | $6.01 | $220.00M | $226.00M | $239.80M | Get Alert |
The last reported Earnings numbers were from April 17, 2024 for the full year 2024 and was for an earnings per share guidance in the range of $4.26 and $4.67 versus the estimated EPS of $4.47.
Browse guidance and forecast on all stocks.